Description
Glifempa 25mg Tablets (30’s)
Glifempa 25mg contains Empagliflozin, a potent SGLT2 inhibitor used for the management of type 2 diabetes mellitus. It helps lower blood sugar levels by increasing glucose excretion through urine.
Key Features:
-
Effective once-daily oral medication for improved glycemic control.
-
Promotes glucose removal via kidneys, aiding in blood sugar reduction.
-
Supports weight loss and may improve cardiovascular and renal outcomes.
-
Can be combined with other antidiabetic therapies for enhanced effect.
-
Convenient dosing enhances patient adherence.
Indications:
-
Treatment of type 2 diabetes mellitus, alone or with other antidiabetic agents.
-
Supports management of blood glucose alongside diet and exercise.
Dosage & Administration:
-
Taken once daily, with or without food.
-
Dosage individualized according to patient response and kidney function.
-
Regular monitoring of blood glucose and renal function is recommended.
Precautions:
-
Not indicated for type 1 diabetes or diabetic ketoacidosis.
-
Use cautiously in patients with renal impairment.
-
Patients should be informed about risks of urinary tract infections and dehydration.
-
Inform healthcare provider of all current medications.
Possible Side Effects:
-
Increased risk of urinary and genital infections.
-
Frequent urination and potential dehydration.
-
Rare but serious ketoacidosis events.
-
Possible hypoglycemia when used with other diabetes medications.
Storage:
-
Store in a cool, dry place away from light and moisture.
-
Keep out of reach of children.
Reviews
There are no reviews yet.